Latest Asx Listing News

Lux Copper has completed its first-ever geophysical survey at the Baird Copper Project in Alaska and is mobilizing two diamond drill rigs ahead of a maiden drilling campaign set for mid-August 2026.

Greenvale Energy has secured $3.25 million through a placement to fast-track uranium exploration at its Thunderball Project in the Northern Territory, while also advancing its Pine Creek acquisition.

WA Gold has delivered a robust scoping study for its Abercromby Gold Project, forecasting strong cashflows and low capital costs, while ramping up drilling at both Abercromby and Bullabulling projects with assay results imminent.

Gateway Mining has expanded its Cowza gold discovery in Western Australia to 3.5 kilometres of continuous high-grade mineralisation, reinforcing the prospect’s potential as a major new gold system within the Yandal Project.

Kali Metals has completed its Phase II drilling at Marble Bar, confirming gold mineralisation continuity and identifying four new high-grade gold prospects, while maintaining a strong cash position of $6.84 million.

Tali Resources has kicked off a broad aircore drilling campaign at its West Arunta Project, backed by a $3 million placement and a $270,000 government grant to fund further prospect testing.

European Lithium (ASX: EUR) has obtained a crucial ASX waiver allowing it to cancel unlisted options and performance rights without shareholder approval, smoothing the path for its acquisition by NASDAQ-listed Critical Metals Corp (NASDAQ: CRML).

Piche Resources (ASX:PR2) has kicked off a $2.5 million non-renounceable entitlement offer to fund exploration in Argentina and potential acquisitions, alongside a key board change.

Radiopharm Theranostics (ASX: RAD) has requested an immediate voluntary suspension of its shares pending a material capital raising announcement expected before markets open on 27 July 2026.

Noronex Limited has struck a deal to acquire the Sleitat Tin Project in Alaska, marking a rare US tin opportunity, while pushing forward with copper and uranium exploration programs in Africa backed by South32.

Invex Therapeutics has broadened its preclinical Alzheimer's program with Tessara Therapeutics, while its cash reserves dipped to $4.02 million in Q4 FY26 amid increased research and administrative costs.

Stelar Metals confirms recent share price and volume spikes are linked to disclosed exploration milestones at its Hill of Leaders Tungsten Project, with no undisclosed information influencing trading.